Strides Pharma receives USFDA popularity of Naproxen Sodium OTC Softgel pills

Strides Pharma receives USFDA popularity of Naproxen Sodium OTC Softgel pills

by admin- Thursday, August 18th, 2022 03:39:08 PM

 

Strides Pharma Science Ltd (Strides) introduced that its step-down completely owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has obtained
approval for Naproxen Sodium Softgel Capsules, 220 mg (OTC) from the United States Food & Drug Administration (USFDA).The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Naproxen Sodium Capsules, 220 mg, of Bionpharma Inc.

News Updates